Niels S. Vermeer
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids.
Journal: Therapeutics and clinical risk management
Published: July 18, 2024
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 06, 2022
Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice.
Journal: Clinical pharmacology and therapeutics
Published: October 03, 2018
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports.
Journal: Drug safety
Published: January 01, 2016
Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.
Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.
Journal: Clinical pharmacology and therapeutics
Published: July 06, 2015
The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.
Journal: Pharmacoepidemiology and drug safety
Published: June 24, 2015
Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab.
Journal: Clinical pharmacology and therapeutics
Published: June 15, 2015
Traceability of biologicals: present challenges in pharmacovigilance.
Journal: Expert opinion on drug safety
Published: November 06, 2014
Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe.
Journal: Clinical pharmacology and therapeutics
Published: June 23, 2014
Harmful effects of proton pump inhibitors: discrepancies between observational studies and randomized clinical trials.
Journal: JAMA internal medicine
Published: September 14, 2013
Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases.
Journal: Drug safety
Published: June 18, 2013
Association of isolated short fetal femur with intrauterine growth restriction.
Journal: Prenatal diagnosis
Published: February 27, 2013
Last Updated: 09/26/2026